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Abstract
Background: Neurons extend their dendrites and axons to build functional neural circuits, which are regulated by both
positive and negative signals during development. Brain-derived neurotrophic factor (BDNF) is a positive regulator for
neurite outgrowth and neuronal survival but the functions of its precursor (proBDNF) are less characterized.
Methodology/Principal Findings: Here we show that proBDNF collapses neurite outgrowth in murine dorsal root ganglion
(DRG) neurons and cortical neurons by activating RhoA via the p75 neurotrophin receptor (p75NTR). We demonstrated that
the receptor proteins for proBDNF, p75NTR and sortilin, were highly expressed in cultured DRG or cortical neurons. ProBDNF
caused a dramatic neurite collapse in a dose-dependent manner and this effect was about 500 fold more potent than
myelin-associated glycoprotein. Neutralization of endogenous proBDNF by using antibodies enhanced neurite outgrowth in
vitro and in vivo, but this effect was lost in p75NTR
2/2 mice. The neurite outgrowth of cortical neurons from p75NTR
deficient (p75NTR
2/2) mice was insensitive to proBDNF. There was a time-dependent reduction of length and number of
filopodia in response to proBDNF which was accompanied with a polarized RhoA activation in growth cones. Moreover,
proBDNF treatment of cortical neurons resulted in a time-dependent activation of RhoA but not Cdc42 and the effect was
absent in p75NTR
2/2 neurons. Rho kinase (ROCK) and the collapsin response mediator protein-2 (CRMP-2) were also
involved in the proBDNF action.
Conclusions: proBDNF has an opposing role in neurite outgrowth to that of mature BDNF. Our observations suggest that
proBDNF collapses neurites outgrowth and filopodial growth cones by activating RhoA through the p75NTR signaling
pathway.
Citation: Sun Y, Lim Y, Li F, Liu S, Lu J-J, et al. (2012) ProBDNF Collapses Neurite Outgrowth of Primary Neurons by Activating RhoA. PLoS ONE 7(4): e35883.
doi:10.1371/journal.pone.0035883
Editor: Alexander G. Obukhov, Indiana University School of Medicine, United States of America
Received December 5, 2011; Accepted March 23, 2012; Published April 27, 2012
Copyright:  2012 Sun et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Health and Medical Research Council (NHMRC grants 595937). Ying Sun was supported by an Australian
Postgraduate Award at Flinders University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Xin-Fu.Zhou@unisa.edu.au
Introduction
Neuronal polarization involving neurite outgrowth and axonal
elongation is essential for building functional neural circuits during
brain development [1,2]. Both positive and negative signals
regulate the neurite outgrowth and guide axons to their
appropriate destinations. Mature neurotrophins (NTs) including
nerve growth factor (NGF), brain-derived neurotrophic factor
(BDNF) and NT-3, NT-4/5 are well characterized positive signals
promoting neurite outgrowth, axonal extension, filopodial protru-
sion and synaptogenesis [3,4].
Proneurotrophins are proteolytically cleaved to form biologi-
cally active mature molecules. Recent studies illustrate that the
neurotrophin precursors, proNGF, proBDNF, and proNT3
trigger apoptosis of sympathetic and sensory neurons to antago-
nize the effects of mature neurotrophins [5,6,7,8]. ProBDNF is
found to be a negative regulator of synaptic plasticity and regulates
long-term depression via p75NTR [9,10]. In addition, it negatively
regulates the migration of cerebellar granule cells during
development and the infiltration of macrophages during spinal
cord injury [11,12]. ProBDNF has distinct functions on different
populations of neurons, reducing the number of cholinergic fibers
and hippocampal dendritic spines without affecting the survival of
these neurons [10]. However, the proBDNF dependent regulation
of neurite outgrowth and the underlying signaling are not known.
A number of factors and signal pathways have been identified to
negatively regulate neurite outgrowth or repulse the growth cones
to cause neurite collapse during development and after nerve
injury in the central nervous system (CNS). These include the
myelin associated factors Nogo, myelin-associated glycoprotein
(MAG) and oligodendrocyte-myelin glycoprotein (OMgp) which
activate Nogo receptors (NgR) and its coreceptor p75NTR in
RhoA dependent manner [13,14]. Additional neurite growth
inhibitory factors such as semaphorin3A, ephrin-B3 or repulsive
guidance molecule b repulse the regeneration of CNS neurons
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35883[15,16,17,18]. Understanding of the functions of molecules which
regulate neurite outgrowth not only sheds the light on the
development of nervous system but also helps to identify potential
therapeutic targets for the promotion of CNS regeneration.
We hypothesize that proBDNF plays opposite roles to those of
mature BDNF in neuronal functions. As mature BDNF is a potent
molecule promoting neurite outgrowth and is an essential
chemoattractant for axonal extension, proBDNF may counteract
and balance the effects of mature BDNF on neurite growth. In the
present study, we have used primary sensory and cortical neurons
to test the hypothesis and were able to demonstrate that exogenous
and endogenous proBDNF collapse neurite outgrowth by
activating the small GTPase RhoA and its downstream effector
Rho kinase (ROCK) via p75NTR.
Results
ProBDNF Collapses Neurites in a Dose-dependent
Manner on Cortical and DRG Neurons
To demonstrate a role of proBDNF in neurite outgrowth, we
first investigated its effects on DRG neurons. Live imaging clearly
showed the collapse of neurites in response to proBDNF (30 ng/
ml, Figure S1) and the enhanced neurite growth in response to
mature BDNF (50 ng/ml, Figure S2, Fig. 1A). ProBDNF caused a
3066% decrease in the neurite length after 6 min (p,0.05) which
was maintained throughout the 30 min treatment (Fig. 1B). To
investigate whether the proBDNF-dependent neurite collapse also
occurs in CNS neurons, we examined its effect on cultured cortical
neurons. The treatment with proBDNF induced in cortical
neurons a decrease in neurite length similar to DRG neurons
(Fig. 1C). To investigate if the effect could be mediated via
endogenous release of proBDNF and subsequent interaction with
its receptors, we determined the protein expression levels of
proBDNF, p75NTR and sortilin in primary cultured cortical and
DRG neurons [19]. ProBDNF was detected as a single band at
35 kD, p75NTR at 75 kD and sortilin at 110 kD. ß-actin with a
single band at 42 kD was used as an internal loading control
(Fig. 1D).
Endogenous Probdnf Inhibits Neurite Growth Through
p75NTR
In this assay, cultured primary adult DRG neurons were treated
with different factors (Fig. 2A–E). The neurite length was
significantly reduced in presence of proBDNF (82.769 mm) but
increased in presence of anti-proBDNF antiserum (326.3614 mm)
or mature BDNF (307.8612 mm) compared to the IgG control
(139.468 mm, p,0.05, Fig. 2F). The results suggest that both
exogenous and endogenous proBDNF inhibits neurite outgrowth
on DRG neurons while mature BDNF enhances the neurite
growth.
The application of proBDNF resulted in dose-dependent
decrease in sensory neuron neurite length compared to untreated
DRG neurons (Fig. 3A, C) with IC50 is about 10 ng/ml. The
p75NTR is also the co-receptor for Nogo receptor which binds the
inhibitory molecule MAG. This allowed us to directly compare the
potency of proBDNF and MAG on the inhibition of the neurite
outgrowth in primary cultured DRG neurons. The application of
MAG (10, 30 mg/ml) resulted in a small but significant decrease in
neurite length (10067 mm, 4664 mm) compared with the control
group (118.466 mm, p,0.05), whereas a lower concentration of
MAG (3 mg/ml) to DRG neurons had no effect (Fig. 3B, D). The
concentration of 30 mg/ml MAG-Fc (MW: 120,000, 250 nM) has
an equivalent effect of, 30 ng/ml proBDNF (dimer MW:
64,000,70,000, 0.42,0.46 nM). Thus proBDNF is
533,583 fold more potent than MAG.
To further investigate whether the p75NTR signaling is
involved in proBDNF effects we applied proBDNF to neurons
dissected from p75NTR
2/2 and p75NTR
+/+ mice. The applica-
tion of proBDNF (30 ng/ml) or MAG (30 mg/ml) decreased the
neurite length by 2167% and 2366% in primary cultured
p75NTR
+/+ DRG neurons (p,0.01, Fig. 3E–G). However, the
treatment of p75NTR
2/2 DRG neurons with proBDNF or MAG
had no effect on neurite outgrowth (p.0.05, Fig. 3H–K).
RhoA Activity is Increased After ProBDNF Treatment but
Lost in p75NTR
2/2 mice
It is known that MAG and Nogo cause neurite collapse by
activating RhoA and this effect is mediated by a direct interaction
of the Rho GDP dissociation inhibitor (Rho-GDI) with p75NTR
[20]. Because proBDNF binds p75NTR with high affinity, we next
tested the hypothesis that proBDNF collapses neurites by
activating RhoA. After treatment with proBDNF for 10 and
20 min, RhoA activity increased 3.961.2 and 4.960.4 fold (Fig.
4A–B). Interestingly, no change in the level of activated Cdc42 was
seen in response to proBDNF (Fig. 4C). Based on these
observations we used the pull-down activity assay to compare
RhoA activity in cortical neurons with or without proBDNF from
p75NTR
+/+ (n=12) and p75NTR
2/2 mice (n=6). The results
showed that, in contrast to cells from p75NTR
2/2 mice,
proBDNF increased RhoA activation in cells from p75NTR
+/+
mice over untreated cells (2.660.2 fold, p,0.01, Fig. 4D).
ProBDNF Activates RhoA and Induces the Collapse of
Growth Cone Filopodia
We detected activated RhoA using specific GTP-RhoA antisera.
As shown in Fig 5A–D, proBDNF treatment caused a time-
dependent increase in GTP-RhoA immunoreactivity in growth
cones. After treatment with proBDNF for 10 and 20 min, GTP-
RhoA immunoreactivity increased 3.760.9 and 5.560.4 fold in
growth cones (Fig. 5I) whereas the immunoreactivity for GTP-
Cdc42 antibody was similar at the different time points (Fig. 5E–
H, 5J).
We next determined whether proBDNF regulates filopodial
length and number (Fig. 5K–N). Filopodia collapsed in response to
proBDNF correlates with RhoA activation in growth cones. After
5, 10 and 20 min, proBDNF caused a significant retraction of
filapodial length from 10.360.6 mm to 6.860.5 mm, 4.361.0 mm
and 3.860.9 mm( p,0.01, Fig. 5O), and decreased the number of
filapodia 860.7, 6.361.0, 6.260.6 (p,0.01, Fig. 5P) relative to
untreated neurons (14.860.9).
ProBDNF Induced Inhibition of Neurite Outgrowth
Depends on the Activation of RhoA and ROCK
Next, we asked whether RhoA and ROCK signaling is involved
in proBDNF-mediated inhibition of neurite outgrowth. C3-
transferase (a molecule that ADP ribosylates RhoA) and Y27632
(a well characterized ROCK inhibitor) were used to inactivate
RhoA and inhibit ROCK, respectively. Functional studies using
the neurite outgrowth assay showed that short-term incubation
(20 min) of cultured DRG neurons with proBDNF significantly
inhibited neurite outgrowth compared with control IgG (Fig. 6A,
B). The extent of inhibition induced by pharmacological inhibitors
of RhoA and ROCK were slightly different (Fig. 6C, D). C3-
transferase reversed the inhibitory effects by 95%, whereas
Y27632 abolished the inhibitory effect of proBDNF completely
(Fig. 6E). GTP-bound RhoA or phosphorylation levels of the
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response to proBDNF but their responses were abolished by
preincubation of these cells with C3 or Y27632 for 30 min and
subsequent stimulation with proBDNF for 20 min (Fig. 6F).
ProBDNF Decreases the Nerve Innervations of Ventral
Planta of the Hind Limb in Vivo Through p75NTR
Finally, we examined whether proBDNF had a similar effect on
fiber growth in vivo. Postnatal day 5 (P5) p75NTR
+/+ and
p75NTR
2/2 mice were injected with proBDNF, anti-proBDNF
or IgG via footpad for 3 days. At P10, the density of total nerve
fibers in the ventral planta was immunostained and quantified
(Fig. 7A–F). Interestingly, in p75NTR
+/+ pups, more nerve fibers
could be seen in the anti-proBDNF group (2.060.2 fold, p,0.001)
compared with the IgG group. In the proBDNF group, the fiber
density was significantly decreased (0.460 fold, p,0.001),
indicating the fibers retracted after proBDNF treatment. However,
this effect was absent when p75NTR
2/2 mice were treated with
proBDNF (Fig. 7G). This suggests that endogenous proBDNF may
play a negative role in the innervations of tissue in vivo through
p75NTR.
Discussion
The morphology of axons and dendrites of neurons depends on
the dynamics of the cytoskeleton which is regulated by diffusing
factors from the environment, extracellular matrix, cell surface
receptors and intracellular signals [21]. BDNF and other mature
neurotrophins are important factors regulating neurite outgrowth
and neuronal differentiation during development. However, the
physiological function of proneurotrophins such as proBDNF in
neurite outgrowth remains unclear. Our hypothesis is that
endogenously released neuronal proBDNF may oppose functions
of mature BDNF [22,23,24]. ProBDNF is highly expressed in
DRG neurons and cortical neurons, can change transport
Figure 1. ProBDNF treatment decreases neurite length on DRG or cortical neurons. A, Time-lapse recordings show the collapsed neurite
growth with proBDNF (left), and enhanced neurite growth with BDNF (right). Frames indicate 5, 10, 20, 30 min respectively. Scale bar, 20 mm. B,
Treatment of DRG neurons with proBDNF decreased the rate of neurite extension within 3 min and remained decelerated through 30 min. n=30
neurites/treatment. *p,0.05, **p,0.001, compared to BSA; Student `s t test. C, Treated cortical or DRG neurons with proBDNF caused similar collapse
in neurite length. n=83–85 neurons/treatment. *p,0.05, **p,0.001, significantly different from untreated neurons; Student `s t test. D, Expression of
sortilin, p75NTR on the lysate of cultured cortical or DRG neurons processed for Western blot. Bands of 35 kDa of proBDNF, 75 kDa of p75NTR, and
110 kDa of sortilin were detected with their respective antibodies. ß-actin (42 kD) antibody was used as internal protein loading control. n=3
independent experiments.
doi:10.1371/journal.pone.0035883.g001
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regulator via the p75NTR for the migration of cerebellar granule
cells [11]. In the present study using a live cell imaging methods
and immunostaining, we show that proBDNF is a potent neurite
collapsing factor. The effect of proBDNF on neurite growth of
neonatal cortical neurons is the same as in adult sensory DRG
neurons. Most importantly, we have found that the neutralization
of proBDNF with antibodies which recognize the prodomain of
proBDNF shows a very robust increase in neurite outgrowth both
in vitro and in vivo. The effect of the neutralization antibody on
neurite growth is at least comparable to that of mature BDNF.
Despite of some controversy regarding proBDNF distribution and
release [28,29], proBDNF has been detected in a number of brain
regions by Western blot and immunohistochemistry [27,30].
These studies strongly indicate that endogenous proBDNF may
have physiological and pathological functions on axonal growth
and guidance.
Neurotrophins bind two kinds of receptors, tropomyosin
receptor kinase (Trk) family and p75NTR, to mediate diverse
functions during nerve development and in the adult brain.
p75NTR is normally co-expressed with all Trks and modulates the
Trks survival response of neurons. On the other hand, p75NTR is
the coreceptor of NgR and the p75NTR/NgR complex mediates
neurite outgrowth inhibition in vitro by MAG, OMgp, and Nogo
[13,14,18]. Thus, during the development, neurite outgrowth
depends on the balance mediated by p75NTR between positive
signals stimulated by neurotrophins and negative signals from
these myelin components in their environment [20,31]. Simple
deletion of p75NTR causes a retardation of axonal elongation in
the periphery of developing mice [32] but significantly increases
axonal growth in the central nervous system [33], indicating the
importance of environmental factors in neurite growth regulated
by p75NTR. In the present study we have identified that
proBDNF is a potent neurite collapsing factor which activates
RhoA via p75NTR to regulate neurite growth. As proBDNF and
BDNF are anterogradely transported and are likely released
concomitantly together in an activity dependent manner
[22,23,24], proBDNF may play an antagonizing role in axonal
elongation and dendritic arborization. Our in vivo data showed that
blocking endogenous proBDNF dramatically increased the neurite
outgrowth in the ventral planta, supporting the notion that
proBDNF may be a physiological factor counteracting mature
BDNF to maintain the balance of innervating territory. Recent
studies by Miller’s group showed that p75NTR regulates dendritic,
axonal pruning and axonal degeneration during development
[18,34]. Extracellular shedding of p75NTR can antagonize the
inhibitory effect of myelin associated proteins on neurite
outgrowth [35], indicating the soluble extracellular domain of
p75NTR can block inhibitory factors. As p75NTR and sortilin are
coreceptors for proBDNF [19,36] and both are expressed in
primary sensory neurons and primary cortical neurons, proBDNF
may act as an autocrine or paracrine factor. In this study, we
confirmed that the proBDNF, p75NTR and sortilin, are highly
expressed on DRG and cortical neurons. Our studies show that
altering the balance by application of anti-proBDNF antibodies to
neutralize endogenous proBDNF can promote neurite outgrowth
and axonal elongation, suggesting that proBDNF is normally
released and functional. As no effect of anti-proBDNF is seen in
DRG neurons of p75NTR
2/2 mice, it is most likely that the full
length proBDNF, rather than the prodomain fragment which does
Figure 2. ProBDNF decreases neurite length on DRG neurons in vitro. Cultured DRG neurons were treated by different factors as shown,
immunofluorescence stained by anti-MAP2 antibody. A, Normal sheep IgG. B, ProBDNF. C, Anti-proBDNF. D, BDNF. E, Anti-proBDNF. F, The neurite
outgrowth assay were analyzed under the different culture conditions. Scale bar, 50 mm. n=89,92 neurons/treatment from three independent
dishes. *p,0.05, **p,0.01, compared to IgG; one-way ANOVA with least-significant difference post hoc test.
doi:10.1371/journal.pone.0035883.g002
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collapse.
To further confirm the inhibitory effect of proBDNF on neurite
growth, we used MAG as the positive control [37,38] to compare
their effects. Both dose-dependently inhibit neurite growth but
proBDNF is 533,583 fold more potent than MAG. As
endogenous myelin-associated inhibitors are considered major
impediments to regeneration after nerve injury, a myriad of
strategies are applied to suppress these factors for promoting
regeneration [39,40,41]. However the results are disappointing as
the elimination of MAG, Nogo, OMgp or Semaphorin-mediated
inhibition are not sufficient to promote extensive axon repair after
spinal cord injury [41,42]. These studies suggest that these
inhibitors do not play a major role in CNS axon degeneration
[43]. In the present study, we found that proBDNF is over 500
more potent than MAG in collapsing neurites, suggesting that
proBDNF can be one of the potent inhibitors for nerve
regeneration after CNS injury. In particular, when axons are
injured, proBDNF is anterogradely transported to the injury sites
then accumulates in the injured axonal bulb in the spinal cord
[25]. It is likely that the accumulated proBDNF is released to
collapse growth cones of CNS axons and prevent the regeneration
of injured neurons. Thus the suppression of endogenous proBDNF
and other proneurotrophins following CNS injury may promote
regeneration of injured nerves.
Filopodia can detect environmental cues to transduce signals
which then guide growth cone directions and dynamics [21,44].
Growth cone turning was induced by the guidance cue, BDNF,
and by the repellent factor, MAG [45]. In this study, we confirmed
that proBDNF participates in growth-cone morphology and
motility by reducing the length and number of filopodia. It is
also likely that during development, proBDNF may function to
Figure 3. ProBDNF collapses neurite length in vitro through p75NTR. A, Cultured DRG neurons were treated by proBDNF (3 ng/ml, 30 ng/ml)
or myelin-associated glycoprotein (MAG 3 mg/ml, 30 mg/ml), respectively, immunofluorescence stained by anti-MAP2 antibody. C, proBDNF
decreased neurite length on DRG neurons in a dose-dependent manner. **p,0.01, compared to untreated neurons; Student `s t test. D, MAG
decreased neurite length of DRG neurons in a dose-dependent manner. *p,0.05, **p,0.01, compared to untreated neurons; Student’s t test. E–G,
Anti-MAP2 staining of p75NTR
+/+ DRG neurons treated by control, proBDNF, MAG, respectively. H–J, Anti-MAP2 staining of p75NTR
2/2 DRG neurons
treated by control, proBDNF, MAG, respectively. K, ProBDNF or MAG treated p75NTR
+/+ DRG neurites displayed significant length decrease compared
with control group. However, proBDNF or MAG treated p75NTR
2/2 DRG neurites had no effect compare with control group. Scale bar, 50 mm.
n=85,90 neurons/treatment. *p,0.05, **p,0.01, compared to control; one-way ANOVA with least-significant difference post hoc test.
doi:10.1371/journal.pone.0035883.g003
Figure 4. ProBDNF increased RhoA activity in cultured cortical neurons through p75NTR. A, Activated and total levels of RhoA or Cdc42
with proBDNF (0, 5, 10, 20 min) treatment which were processed for immunoblot (IB) assay. B, 10 and 20 min exposure to proBDNF caused significant
production in activated RhoA normalized to total RhoA. **p,0.01, compared to untreated neurons; Student `s t test. C, Exposure to proBDNF caused
no differences in activated Cdc42 normalized to total Cdc42. D, RhoA activity increased on p75NTR
+/+ cortical neurons after treated by proBDNF
20 min compared with p75NTR
+/+ control neurons whereas p75NTR
2/2 cortical neurons exhibited no difference. n=3,4 independent experiments.
**p,0.01, compared to control level; Student `s t test.
doi:10.1371/journal.pone.0035883.g004
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axons to their right destination. This is consistent with our
previous work demonstrating that proBDNF repulses the migra-
tion of cerebellar granule neurons and their neurites, whereas
mature BDNF or proBDNF antibodies attract them [11].
Growth cone protrusion and retraction of neurons is due to the
dynamic assembly and disassembly of tubulin and actin cytoskel-
etal proteins. RhoA, Cdc42, Rac1 GTPases provide the necessary
integration sites for the complex regulation of growth cone
motility, cell division, and actin dynamics in neuronal growth
[4,46]. Over expression of dominant active forms of Rho initiate
Figure 5. ProBDNF treatment increases RhoA activity and filopodial length on DRG growth cones. A–H, Immunoreactivity of RhoA or
Cdc42 activity in DRG growth cones after proBDNF (0, 5, 10, 20 min) treatment. Scale bar, 10 mm. I, Quantification of RhoA activity. There were
significant inductions after exposure to proBDNF 10, 20 min. *p,0.05, **p,0.01, compared to untreated neurons; Student `s t test. J, Quantification of
Cdc42 activity. There was no change during the whole 20 min exposure of proBDNF. K–N, F-actin of DRG growth cones after proBDNF (0, 5, 10,
20 min) treatment. Scale bar, 5 mm. O, ProBDNF decreased filopodial length on DRG growth cones in a time-dependent manner. P, ProBDNF
decreased filopodia number on DRG growth cones in a time-dependent manner. n=35 neurites/treatment from at least three independent
experiments. **p,0.01, compared to untreated neurons; Student `s t test.
doi:10.1371/journal.pone.0035883.g005
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and promote axonal regeneration [4,47]. Rho proteins, like other
members of the Ras superfamily, have been shown to control the
actin cytoskeleton by the active cycle changes between active
GTP-bound and inactive GDP-bound states. p75NTR interacts
with Rho-GDI which is stimulated by MAG, initiating the
activation of RhoA to inhibit the growth [48,49]. We found that
RhoA-GTPase is immediately activated in response to proBDNF,
which was dependent on p75NTR. It is likely that the binding of
proBDNF to p75NTR directly stimulates the interaction with
Rho-GDI and promotes the generation of RhoA-GTPase which
causes the subsequent collapse growth cones and filopodia.
The activation of RhoA and its downstream effector ROCK
leads to growth cone collapse and neurite growth arrest, a
mechanism that has been extensively studied in experiments on
the myelin-associated inhibitors MAG, Nogo, and OMgp [50,51].
To directly link the proBDNF-induced activation of RhoA and
ROCK with inhibition of neurite outgrowth, pharmacological
approaches were used to prevent the activation to abrogate the
deleterious effects of the proBDNF. The reversal of inhibition with
C3-transferase was less than that of Y27632, and this may be
attributable to relatively lower cell permeability of C3-transferase
[52]. Our studies show that the inhibition induced by proBDNF is
via engagement of activation of RhoA and its downstream effector
ROCK.
In the present study, using p75NTR
2/2 neurons and mice we
could show that p75NTR is the proBDNF downstream signal
molecule which is essential for the neurite collapse. We found that
proBDNF neurite collapsing effect in vitro and in vivo are lost in
p75NTR
2/2 neurons and in p75NTR
2/2 mice. Furthermore, we
found that the RhoA activation by proBDNF was also abolished in
p75NTR
2/2 neurons. These data indicate that p75NTR is
responsible for the action of proBDNF. Our data raise a question
of how to reconcile the contradictory roles of p75NTR in neurite
growth/collapse. Yamashita et al. showed that mature neurotro-
phins inhibit RhoA in the absence of Trk receptors, promoting
neurite growth [48]. Recently, Yamashita’s group discovered
another pathway demonstrating that p75NTR may activate paired
immunoglobulin-like receptor B (PIR-B) which recruits Src
homology 2-containing protein tyrosine phosphatise (SHP)-1 and
SHP-2, that dephosphorylates Trk receptors and reduces neurite
growth [53]. The activation by mature neurotrophins of p75NTR
in the presence or absence of Trk receptors would promote neurite
growth via inactivation of RhoA and/or activation of the
phosphatidylinositide 3 kinase (PI3K) and the mitogen-activated
protein kinase (MAPK) pathway [48,54,55,56]. On the other
hand, the activation of p75NTR by proneurotrophins and/or
myelin inhibitory factors in the absence of Trk or low levels Trk
receptors in neurons would activate RhoA and suppress the signal
transduction of Trk/MAPK, leading to the neurite collapse and
degeneration. Thus, activation or inactivation of RhoA signaling
pathway via the p75NTR is ligand- and coreceptor-dependent.
The double-faced actions of p75NTR on neurite growth explains
why no enhanced nerve regeneration is seen in p75NTR
2/2 mice
after spinal cord injury [57].
The function of p75NTR in neurite growth does not only
depend on neuronal expression of p75NTR, but also on the glial
expression of p75NTR [58]. This interrelationship between
different cell types expressing p75NTR is even more complicated
Figure 6. ProBDNF inhibits neurite growth through activation
of RhoA and ROCK. Cultured DRG neurons were treated by different
factors, followed by labelling of anti-MAP2 using immunocytochemistry.
A, Treatment with normal sheep IgG. B, DRG neurons treated with
proBDNF have shorter neurites. C, Pretreatment with C3-transferase
(RhoA inhibitor) reverses proBDNF induced inhibition of neurite growth.
D, Y27632 (ROCK inhibitor) completely reverses the proBDNF induced
inhibition. Scale bar, 50 mm. E, Neurite outgrowth assay. ProBDNF
significantly reduced the neurite length whereas pretreatment with C3
or Y27632 restored the reduction. n=91,95 neurons/treatment from
three independent experiments. *p,0.01; Student `s t test. F, GTP-RhoA
was measured by pull-down assay. Activated CRMP-2 and total RhoA
and ß-actin are also shown by immunoblot (IB). Lane 1, normal sheep
IgG control group. Lane 2, proBDNF-induced RhoA activation. Lane 3,
The RhoA inhibitor C3 abolishes proBDNF-induced RhoA activation.
Lane 4, ROCK inhibition Y27632 blocks proBDNF-induced RhoA
activation. Phosphorylation of the collapsin response mediator pro-
tein-2 (P-CRMP-2) was assessed with phospho-specific antisera. ß-actin
was used as internal protein loading control. n=3 independent
experiments.
doi:10.1371/journal.pone.0035883.g006
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express p75NTR and have been reported to affect peripheral
nerve regeneration [59], p75NTR is highly expressed by
peripheral neurons and also Schwann cells after Wallerian
degeneration. We and others showed that Schwann cell
p75NTR positively regulates nerve regeneration. The depletion
of p75NTR causes retardation of peripheral nerve regeneration
after nerve injury [57,60,61] and reduces the nerve elongation
during development [32,62].
In summary, proBDNF is a powerful neurite outgrowth
inhibitor which activates RhoA via p75NTR. ProBDNF also
decreases filopodial length and number of growth cones and
triggers a polarized distribution of activated RhoA in the tips of
growth cones. Neutralization of endogenous proBDNF enhances
the innervation. Endogenous proBDNF may play an opposing role
to that of mature BDNF regulating neurite growth.
Materials and Methods
Animals and Reagents
All experimental procedures were under the guidelines of the
National Health and Medical Research Council of Australia and
Figure 7. ProBDNF decreases the nerve innervation in ventral planta skin in vivo through p75NTR. A–C, Anti-neurofilament staining of
footpad treated by normal sheep IgG (IgG), proBDNF, anti-proBDNF, respectively on p75NTR
+/+ postnatal 5 days animals. D–F, Anti-neurofilament
staining of footpad treated by IgG, proBDNF, anti-proBDNF, respectively on p75NTR
2/2 postnatal 5 days animals. G, Quantification of nerve fiber
density. The maximal threshold of control IgG fiber density (area occupied/total area of field of view) was defined as 1, for the treatments, density of
the fibers was divided by the IgG fiber density in the same optical field. ProBDNF reduced the nerve fibers density while anti-proBDNF increased the
nerve fibers density on p75NTR
+/+ animals. However, proBDNF or anti-proBDNF had no effect in p75NTR
2/2 mice. Scale bar, 100 mm. n=40 sections/
treatment from five independent animals. *p,0.01, compared to IgG; Student `s t test.
doi:10.1371/journal.pone.0035883.g007
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University. Adult 8–10 weeks old Sprague-Dawley (SD) rats
(n=12), neonatal 129 sv wild-type (p75NTR
+/+, n=24), postnatal
day 5 (P5, p75NTR
+/+, n=15), p75NTR deficient mice
(p75NTR
2/2, n=12) were used.
Recombinant proBDNF with a RR-AA mutation of the
cleavage site and the neutralizing proBDNF antiserum were
produced in our lab and their biological activities have been
characterized [63]. The antisera directed against proBDNF for
immunohistochemistry have been characterised [27]. The neu-
tralizing antiserum specifically recognize proBDNF but not
mature BDNF and other neurotrophins [11,12,25,26,63]. Culture
media were obtained from Invitrogen and other reagents were
obtained from Sigma (St. Louis, MO) unless specified otherwise.
Primary Neuron Culture
Lumbar dorsal root ganglia (DRG) were dissected from SD rats
(,250 g, n=6) and cut into eight pieces, digested at Collagenase II
Ca
2+ free Hank’s solution as described previously [64]. The tissues
were dissociated using a fire-polished Pasteur pipette, the cell
suspension was layered on top of a 15% fatty acid-free albumin
bovine serum (BSA, Sigma) solution. After a 400 g centrifugation
for 20 min the pellet was resuspended in Neurobasal medium
(Invitrogen) containing 0.25% foetal calf serum (FCS, Invitrogen),
penicillin–streptomycin (100 U), L-glutamine (2 mM) and B27
(2%) serum-free supplement (Invitrogen). The number of viable
cells was determined by trypan blue (Sigma) exclusion and 2610
4
DRG cells were plated onto poly-D-lysine-coated cell culture
dishes and cultured at 37uC in 95% O2 ?5 %C O 2 incubator.
Cultured DRG neurons were treated with proBDNF (0, 3, 10, 30,
100 ng/ml), anti-proBDNF (10 mg/ml), BDNF (50 ng/ml), nor-
mal sheep IgG (IgG, 10 mg/ml) or recombinant rat MAG-Fc
chimera (0, 3, 10, 30 mg/ml, R&D Systems, USA).
For primary cortical neuron cultures, p75NTR
+/+ (n=12),
p75NTR
2/2 (n=6) mice postnatal day 1 (P1) were killed, neurons
were purified as described previously [11,65]. Briefly, cortices were
collected, meninges removed and tissue sliced into 0.5 mm pieces.
Tissue blocks were incubated in 1% trypsin ? EDTA (Invitrogen,
Australia) with 0.1% DNaseI (Worthington, NJ, USA) for 8 min at
37uC with shaking every 5 min. Digestion was stopped by adding
15% FCS. After a 400 g centrifugation for 10 min the pellet was
resuspended in 1 ml Neurobasal medium supplemented with B27
(2%), N2 (1%), penicillin–streptomycin (100 U), L-glutamine
(2 mM) and FCS (2%). 1610
6 cortical cells were plated onto
poly-D-lysine-coated cell culture dishes, after 24 h cultured at
37uC in 95% O2 ?5 %C O 2 incubator, neurons were incubated
with BSA as a control, proBDNF or MAG. Neurite length was
measured after 2 h treatment.
Time-lapse Video Microscopy
Phase-contrast images from cultured DRG neurons were
collected using an inverted microscope (BioStation, Nikon, Japan).
Digital images were captured every 30 sec for 30 min, collected
individually and analyzed by Advanced Research software for the
determination of the neurite extension length. The extension rate
was defined as the difference between the length at time point 0
and the time examined and divided by the time period (seconds).
Western Blot of ProBDNF, p75NTR and Sortilin in Cortex
or DRG
The cultured neuron protein concentration for Western Blot
was assayed using a BCA
TM Protein Assay Kit (Pierce, Rockford,
IL, USA). 40 mg of homogenate proteins were denatured by
boiling for 5 min and separated by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE). The nitrocellu-
lose membrane (0.45 mm pore size, GE Healthcare Life Science)
was probed with primary antibodies directed to rabbit anti-
p75NTR (1:1000, G3231, Promega, USA), rabbit anti-sortilin
(1:1000, Osenses, Australia) and a monoclonal antibody to b-actin
(1:1000, Sigma) as the internal control overnight, respectively,
followed by incubation with the horseradish peroxidase (HRP)-
linked secondary antibodies (Jackson Laboratories) at 1:2000 for
1 h at room temperature. Membranes were developed by using
the enhanced chemiluminescence (ECL) system (Amersham
Biosciences).
Indirect Immunofluorescence and Neurite Outgrowth
Assay
For outgrowth assays, primary cultured neurons were fixed with
4% paraformaldehyde (PFA), then incubated overnight with
1:1000 rabbit anti-MAP2 polyclonal antibody (Osenses, Australia)
followed by incubation with Alexa Fluor 488 anti-rabbit secondary
antibody (Jackson Laboratories, USA). Images were acquired from
randomly selected fields (n=8,12) under Fluorescence Micro-
scope (Olympus BX50). The length of the longest neurite of
80,120 neurons per condition was determined using ImageJ
software [66]. Each experimental condition was done in duplicate
wells, and at least three independent experiments were conducted
to acquire the final results.
Activation Assay of RhoA and Cdc42
The proBDNF-dependent activation of RhoA and Cdc42 was
assessed using a pull-down assay kit according to manufacturer
instructions (NewEast Biosciences, USA). Due to the limited
number of DRG neurons we used cortical neurons in this assay.
10
7 cortical cells from p75NTR
+/+ and p75NTR
2/2 mice were
cultured and treated with 30 ng/ml proBDNF for 0, 5, 10,
20 min, and subsequently homogenized and lysed with RIPA
buffer containing protease inhibitors (Roche Applied Science).
One aliquot was used for immunoblot (IB) analysis, the second
aliquot was incubated with GTP-RhoA or GTP-Cdc42 antibody,
bound with protein A/G agarose beads for 1 h at 4 uC,
precipitated and subjected to SDS-PAGE, detected by anti-RhoA
or anti-Cdc42 antibodies. GTP-activated levels were normalized
to the corresponding total RhoA levels using densitometric analysis
using ImageJ software. The data were expressed as a percentage of
the signals obtained at 5, 10 and 20 min in comparison with the
time point 0.
Immunohistochemical Detection of Activated RhoA and
Cdc42
Primary cultured rat DRG neurons (n=6) were exposed to
proBDNF for 0, 5, 10, 20 min, fixed with 4% PFA and incubated
with antisera directed against GTP-RhoA or GTP-Cdc42 (New-
East Biosciences, USA) respectively, followed by incubation with
Alexa Fluro 594 anti-mouse secondary antibody (Jackson Labo-
ratories, USA). The presence of GTP-activated RhoA or Cdc42 in
growth cones was quantified by measuring signal intensity in each
growth cone using ImageJ. For F-actin staining, primary cultured
DRG neurons were fixed with 0.25% glutaraldehyde, quenched
with 1 mg/ml sodium borohydride for 15 min, followed by
incubation rhodamine-conjugated phalloidin (Molecular Probes,
USA). The staining of growth cones were captured using a
confocal microscope (Leica SP5, Germany).
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The chemical approach included treatment of cultured DRG
neurons with the RhoA inhibitor, C3-transferase (25 mg/ml;
Cytoskeleton), and/or the ROCK inhibitor, Y27632 (10 mM;
Calbiochem), before adding proBDNF (30 ng/ml). 2610
4 cul-
tured DRG neurons were treated after 24 h later, neurite length
was measured as above mentioned. Cell lysates were assayed for
activated RhoA and for phosphorylated CRMP-2 (rabbit poly-
clonal anti phosphorylated CRMP-2 affinity purified antibody was
a gift from Dr S. Petratos, Monash University, Clayton, Australia).
In vivo Delivery of Exogenous ProBDNF and its
Neutralizing Antiserum into the Footpad of Pups
10 ml of proBDNF (1 mg), anti-proBDNF (5 mg) or IgG (5 mg)
were injected into the footpad of P5 p75NTR
+/+ and p75NTR
2/
2 mice (n=5/treatment) on three consecutive days. On day ten,
the pups were anesthetized and immobilized perfused through the
heart with 30 ml saline followed by 50 ml Zamboni’s fixative as
described previously [11]. After perfusion, the injected ventral
planta was dissected and post-fixed overnight in the same fixative.
The next day, the planta was cryopreserved in 0.1 M phosphate-
buffered saline +18% sucrose. Sagittal cryostat sections (30 mm
thickness) were cut into five series using a freezing microtome
(Leica, Germany) and mounted on gelatine-coated glass slides as
described previously [11]. The series in every fifth mid-sagittal
sections were used for nerve fiber density quantification. These
sections were blocked using 5% donkey serum for 1 h at room
temperature then incubated with anti-neurofilament antibody
(1:1000, RT97, Abcam, UK) overnight at 4uC, followed by
incubation with Alexa Fluor 594 anti-mouse secondary antibody.
Images were taken from 8 sections per animal under Fluorescence
Microscope (Olympus BX50). The nerve fiber density was
determined by determing the area occupied by nerve fibers at
150 mm intervals using ImageJ program. Five animals per
treatment were used in this study. The data were expressed as a
normalized nerve fiber density using normal sheep IgG group as 1.
Statistical Analysis
The in vivo experiments of footpad injection were carried out in
a double blinded manner. The data are expressed as mean 6
standard error of the mean (SEM). Experiments with intra or inter
group were analyzed by using Student’s t test or one way ANOVA
with Least-significant Difference (LSD) Post Hoc Test. p
values,0.05 were considered statistically significant. All statistical
analyses of the experimental data were performed using 13.0
SPSS.
Supporting Information
Figure S1 ProBDNF treatment decreases neurite length on
cultured DRG neurons.
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